Construct: ORF ccsbBroad304_02426

Construct Description:

Construct Type:
ORF
Other Identifiers:
ORF006258.1_s304c1, BRDN0000403267
Derived from:
ccsbBroadEn_02426
DNA Barcode:
None
Epitope Tag:
V5
Notes:
No stop codon in insert

Originally Annotated References:

Gene:
ARIH2 (10425)

Vector Information:

Vector Backbone:
pLX_304
Pol II Cassette 1:
PGK-BlastR
Pol II Cassette 2:
CMV-ccsbBroad304_02426
Selection Marker:
BlastR
Visible Reporter:
n/a
Epitope Tag:
n/a

Current transcripts matched by this ORF:

Taxon Gene Symbol Description Transcript Nuc. Match %[?] Prot. Match %[?] Match Diffs[?]
1 human 10425 ARIH2 ariadne RBR E3 ubiquitin pr... NM_001317333.2 100% 100%
2 human 10425 ARIH2 ariadne RBR E3 ubiquitin pr... NM_001349209.2 100% 100%
3 human 10425 ARIH2 ariadne RBR E3 ubiquitin pr... NM_001349210.2 100% 100%
4 human 10425 ARIH2 ariadne RBR E3 ubiquitin pr... NM_001349211.2 100% 100%
5 human 10425 ARIH2 ariadne RBR E3 ubiquitin pr... NM_006321.4 100% 100%
6 human 10425 ARIH2 ariadne RBR E3 ubiquitin pr... XM_024453309.1 100% 100%
7 human 10425 ARIH2 ariadne RBR E3 ubiquitin pr... NM_001349213.2 95.5% 95.3% 962_1030del
8 human 10425 ARIH2 ariadne RBR E3 ubiquitin pr... NM_001349214.2 95.5% 95.3% 962_1030del
9 human 10425 ARIH2 ariadne RBR E3 ubiquitin pr... XM_011533267.2 95.5% 95.3% 962_1030del
10 human 10425 ARIH2 ariadne RBR E3 ubiquitin pr... XM_011533268.1 95.5% 95.3% 962_1030del
11 human 10425 ARIH2 ariadne RBR E3 ubiquitin pr... XM_024453308.1 95.5% 95.3% 962_1030del
12 human 10425 ARIH2 ariadne RBR E3 ubiquitin pr... NM_001349215.2 95.1% 85.6% 1256_1281del;1458_1459ins47
13 human 10425 ARIH2 ariadne RBR E3 ubiquitin pr... NM_001349217.2 83.9% 82.6% (many diffs)
14 human 10425 ARIH2 ariadne RBR E3 ubiquitin pr... NM_001349218.2 83.9% 82.6% (many diffs)
15 human 10425 ARIH2 ariadne RBR E3 ubiquitin pr... NM_001349219.2 83.9% 82.6% (many diffs)
16 human 10425 ARIH2 ariadne RBR E3 ubiquitin pr... NM_001349220.2 83.9% 82.6% (many diffs)
17 human 10425 ARIH2 ariadne RBR E3 ubiquitin pr... NM_001349221.2 83.9% 82.6% (many diffs)
18 human 10425 ARIH2 ariadne RBR E3 ubiquitin pr... XM_017005536.2 83.9% 82.6% (many diffs)
19 human 10425 ARIH2 ariadne RBR E3 ubiquitin pr... NM_001349222.2 82.8% 82.7% 0_1ins252;2T>A
20 human 10425 ARIH2 ariadne RBR E3 ubiquitin pr... NM_001349223.2 82.8% 82.7% 0_1ins252;2T>A
21 human 10425 ARIH2 ariadne RBR E3 ubiquitin pr... NM_001349224.2 82.8% 82.7% 0_1ins252;2T>A
22 human 10425 ARIH2 ariadne RBR E3 ubiquitin pr... NM_001349225.2 82.8% 82.7% 0_1ins252;2T>A
23 human 10425 ARIH2 ariadne RBR E3 ubiquitin pr... NM_001349226.2 82.8% 82.7% 0_1ins252;2T>A
24 human 10425 ARIH2 ariadne RBR E3 ubiquitin pr... XM_024453310.1 82.8% 82.7% 0_1ins252;2T>A
25 human 10425 ARIH2 ariadne RBR E3 ubiquitin pr... NM_001349216.2 80.1% 78.8% (many diffs)
26 human 10425 ARIH2 ariadne RBR E3 ubiquitin pr... XM_011533271.1 80.1% 78.8% (many diffs)
27 human 10425 ARIH2 ariadne RBR E3 ubiquitin pr... XM_017005533.2 80.1% 78.8% (many diffs)
28 human 10425 ARIH2 ariadne RBR E3 ubiquitin pr... XM_017005534.1 80.1% 78.8% (many diffs)
29 human 10425 ARIH2 ariadne RBR E3 ubiquitin pr... XM_017005535.1 80.1% 78.8% (many diffs)
30 human 10425 ARIH2 ariadne RBR E3 ubiquitin pr... XM_011533273.1 79.1% 78.8% 0_1ins252;2T>A;710_778del
31 human 10425 ARIH2 ariadne RBR E3 ubiquitin pr... NM_001317334.2 71.1% 71.1% 0_1ins426
32 human 10425 ARIH2 ariadne RBR E3 ubiquitin pr... NM_001349212.2 71.1% 71.1% 0_1ins426
33 human 10425 ARIH2 ariadne RBR E3 ubiquitin pr... XM_024453311.1 68% 67.8% 0_1ins426;536_604del
34 human 10425 ARIH2 ariadne RBR E3 ubiquitin pr... NM_001349227.2 60% 59.8% 0_1ins549;413_481del
35 human 10425 ARIH2 ariadne RBR E3 ubiquitin pr... XM_011533276.1 44.7% 44.5% 0_1ins786;176_244del
36 human 10425 ARIH2 ariadne RBR E3 ubiquitin pr... NR_146083.2 29.2% 1_318del;1207_1358del;1950_5064del
37 human 10425 ARIH2 ariadne RBR E3 ubiquitin pr... NR_146082.2 28.5% 1_440del;1329_1480del;2072_5186del
38 human 10425 ARIH2 ariadne RBR E3 ubiquitin pr... NR_146085.2 27.9% (many diffs)
39 human 10425 ARIH2 ariadne RBR E3 ubiquitin pr... NR_146084.2 27.7% (many diffs)
40 human 10425 ARIH2 ariadne RBR E3 ubiquitin pr... NM_001349228.2 19.1% 17.8% (many diffs)
41 human 10425 ARIH2 ariadne RBR E3 ubiquitin pr... NM_001349229.2 19.1% 17.8% (many diffs)
42 human 10425 ARIH2 ariadne RBR E3 ubiquitin pr... NM_001349230.2 19.1% 17.8% (many diffs)
43 mouse 23807 Arih2 ariadne RBR E3 ubiquitin pr... NM_011790.4 91.4% 98.1% (many diffs)
44 mouse 23807 Arih2 ariadne RBR E3 ubiquitin pr... XM_006511725.2 91.4% 98.1% (many diffs)
45 mouse 23807 Arih2 ariadne RBR E3 ubiquitin pr... XM_006511728.3 77% 81.4% (many diffs)
46 mouse 23807 Arih2 ariadne RBR E3 ubiquitin pr... XM_011242881.2 54.9% 58.6% (many diffs)
47 mouse 23807 Arih2 ariadne RBR E3 ubiquitin pr... XR_871083.2 32.7% (many diffs)
Download CSV

Sequence Information

Note: uppercase bases indicate empirically verified sequence.

ORF start:
66
ORF end:
1545
ORF length:
1479
Sequence:
1ggtctatata agcagagctc tctggctaac tgtcgggatc aacaagtttg tacaaaaaag
61ttggcatgtc agtggacatg aatagccagg ggtctgacag caatgaagag gactatgacc
121caaattgtga ggaagaggaa gaagaagaag aagacgaccc tggggacata gaggactatt
181acgtgggagt agccagcgat gtggagcagc agggggctga tgcctttgat cccgaggagt
241accagttcac ttgcttgacc tacaaggaat ctgagggtgc cctcaatgag cacatgacca
301gcttagcttc tgtcctaaag gtatctcatt cagttgctaa acttatatta gttaatttcc
361actggcaagt ttcagagata ttggacagat acaagtccaa ttctgctcaa ctgcttgttg
421aggctcgagt tcagcctaat ccatcaaaac atgttcccac atcccatccc cctcaccact
481gtgcagtgtg tatgcagttt gtgcgaaagg aaaacctact ctctctggcc tgtcagcacc
541agttttgccg cagctgctgg gagcagcact gctcagttct cgtcaaggac ggcgtgggcg
601tgggagtctc ttgcatggct caggactgtc cactccgtac accagaggac tttgtgtttc
661cattgcttcc caatgaagaa ttgagagaga aatacaggcg ctacctcttc agggactatg
721tggagagtca ttaccagctc cagctgtgcc ctggtgcaga ctgccccatg gttattcggg
781tacaggagcc tagagctcgc cgagtacagt gcaatcggtg caacgaggtc ttctgtttca
841agtgtcgtca gatgtatcac gcacccacag actgtgccac aatccggaaa tggctcacga
901agtgtgcaga cgactctgaa acagccaact acattagtgc tcacactaaa gactgtccca
961agtgcaacat ctgcattgag aagaatggag gctgcaatca catgcaatgc tccaaatgta
1021aacacgactt ctgctggatg tgtctaggag attggaagac tcatggcagt gaatactatg
1081agtgcagtcg ttacaaggag aatcctgaca tcgtgaacca gagccaacaa gcccaggcga
1141gggaagccct caagaagtac ttattctact ttgagaggtg ggaaaaccac aataaaagct
1201tgcagctaga ggcacagaca taccagcgga ttcacgagaa gattcaggag agggtcatga
1261acaatctggg gacatggatc gactggcagt acctacagaa tgctgccaag ctcttggcca
1321agtgtcgata caccctgcaa tacacctacc catatgcata ttacatggag tccggaccca
1381ggaagaagct gtttgaatac cagcaggctc agctggaggc tgagatcgaa aacctctcat
1441ggaaagtgga gcgtgcagac agctatgaca gaggggactt ggagaaccag atgcatatag
1501cggagcagcg gaggagaacc ctgctgaaag atttccatga cacctaccca actttcttgt
1561acaaagtggt tggtaagcct atccctaacc ctctcctcgg tctcgattct acgtagtaat
1621gagctagcgc taaccggtgg cgcgttaagt cgacaatcaa cctctggatt a

Download FASTA (ORF) (Full)

GPP Web Portal Terms of Service

Effective Date: December 8, 2025
By using this site, you agree to our terms and conditions below.

Overview of Terms

The data made available on this website were generated for research purposes and are not intended for clinical or commercial uses. Commercial use (or other use for profit-making purposes) of the GPP Web Portal and its tools, is not permitted under these terms and may require a separate license agreement from Broad or its contributors. For more information, please contact partnering@broadinstitute.org.

The original data may be subject to rights claimed by third parties, including but not limited to, patent, copyright, other intellectual property rights, biodiversity-related access and benefit-sharing rights. It is the responsibility of users of Broad Institute services to ensure that their use of the data does not infringe any of the rights of such third parties.

Any questions or comments concerning these Terms of Use can be addressed to: legal@broadinstitute.org.

By accessing and viewing this GPP Web Portal, you agree to the following terms and conditions:

Attribution

You agree to acknowledge the Broad Institute (e.g., in publications, services or products) for any of your use of its online services, databases or software in accordance with good scientific practice. You agree to use the acknowledgment wording provided for the relevant tools as indicated on the FAQ for each tool.

Updating the Terms of Use

We reserve the right to update these Terms of Use at any time. When alterations are inevitable, we will attempt to give reasonable notice of any changes by placing a notice on our website, but you may wish to check each time you use the website. The date of the most recent revision will appear on this, the "GPP Web Portal Terms of Use" page. If you do not agree to these changes, please do not continue to use our online services. We will also make available an archived copy of the previous Terms of Use for comparison.

Indemnification and Disclaimer of Warranties

You are using this GPP Web Portal at your own risk, and you hereby agree to hold Broad and its contributors and their trustees, directors, officers, employees, and affiliated investigators harmless for any third party claims which may arise from your use of the GPP Web Portal, the tools available therein, or any portion thereof. Further, you agree to indemnify Broad, its contributors, and its and their trustees, directors, officers, employees, affiliated investigators, students, and affiliates for any loss, costs, claims, damages, or other liabilities arising from any unpermitted commercial or profit-making use you make of the GPP Web Portal. The GPP Web Portal is a research tool and is provided "as is". Broad does not represent that the GPP Web Portal is free of errors or bugs or suitable for any particular tasks.

ANY EXPRESS OR IMPLIED WARRANTIES, INCLUDING, BUT NOT LIMITED TO, THE IMPLIED WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, NONINFRINGEMENT, OR THE ABSENCE OF LATENT OR OTHER DEFECTS ARE DISCLAIMED. IN NO EVENT SHALL BROAD OR ITS CONTRIBUTORS BE LIABLE FOR ANY DIRECT, INDIRECT, INCIDENTAL, SPECIAL, EXEMPLARY, OR CONSEQUENTIAL DAMAGES HOWEVER CAUSED AND ON ANY THEORY OF LIABILITY, WHETHER IN CONTRACT, STRICT LIABILITY, OR TORT (INCLUDING NEGLIGENCE OR OTHERWISE) ARISING IN ANY WAY OUT OF THE USE OF THE GPP WEB PORTAL, EVEN IF ADVISED OF THE POSSIBILITY OF SUCH DAMAGE.

Governing Law

The terms and conditions herein shall be construed, governed, interpreted, and applied in accordance with the internal laws of the Commonwealth of Massachusetts, U.S.A. Furthermore, by accessing, downloading, or using the Database, You consent to the personal jurisdiction of, and venue in, the state and federal courts within Massachusetts with respect to Your download or use of the Database.